Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody directed against tyrosinase-related protein (TYRP1).Flanvotumab exhibits potent antitumor activity and acts through natural killer-mediated and antibody-dependent cell-mediated cytotoxicity (ADCC
CAS Number:
[1188277-05-5]
Target:
Tyrosinase
* VAT and and shipping costs not included. Errors and price changes excepted